Neo Ivy Capital Management Albemarle Corp Transaction History

Neo Ivy Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$172.09 - $246.0 $78,989 - $112,914	-459 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$214.16 - $283.8 $14,777 - $19,582	-69 Reduced 13.07%	459 $107,000
Q3 2021 Nov 16, 2021	BUY	$167.91 - $244.03 $88,656 - $128,847	528 New	528 $41,000
Q3 2020 Nov 17, 2020	SELL	$75.75 - $100.45 $57,342 - $76,040	-757 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$52.7 - $86.74 $12,068 - $19,863	229 Added 43.37%	757 $58,000
Q2 2020 Aug 17, 2020	SELL	$52.7 - $86.74 $43,793 - $72,080	-831 Reduced 61.15%	528 $41,000
Q1 2020 May 15, 2020	BUY	$50.9 - $94.31 $69,173 - $128,167	1,359 New	1,359 $77,000
Q3 2019 Nov 21, 2019	SELL	$59.3 - $75.53 $44,890 - $57,176	-757 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$63.3 - $86.94 $47,918 - $65,813	757 New	757 $53,000

946

109M

6.73M

10.4M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $11.5B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.